Clinical Trial Update: A Phase 2 Trial of IW-1973, A Stimulator of Soluble Guanylate Cyclase (sGC), in Patients With Stable Type 2 Diabetes and Hypertension [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating IW-1973, a stimulator of soluble guanylate cyclase (sGC), in patients with stable type 2 diabetes and hypertension has completed with p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Type 2 Diabetes Mellitus

Drugs mentioned

• IW-1973 (IW-1973)

Snippet

Sponsor: Cyclerion Therapeutics | Conditions: Diabetes Mellitus, Type 2, Hypertension | Phase 2 | Status: COMPLETED | Results posted: 2020-04-16